ArticleEuropean journal of clinical pharmacology2009
The Italian Horizon Scanning Project.
Article in European journal of clinical pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Towards greater impact in health technology assessment: System dynamic approach for new and emerging technologies in Iran.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024Article
- "Ready for the future?" - Status of national and cross-country horizon scanning systems for medicines in European countries.German medical science : GMS e-journal · 2022Review
- A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development.Medical journal of the Islamic Republic of Iran · 2021Article
- Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.Frontiers in public health · 2018Review
- The Early Awareness and Alert System in Sweden: History and Current Status.Frontiers in pharmacology · 2017Review
- Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.Frontiers in pharmacology · 2016Article
- The role of health technology assessment bodies in shaping drug development.Drug design, development and therapy · 2014Article
- Personalizing health care: feasibility and future implications.BMC medicine · 2013Review
- Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.BMC health services research · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
19495735What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.